Optical Aptamer Probes of Fluorescent Imaging to Rapid Monitoring of Circulating Tumor Cell.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27886058)

Published in Sensors (Basel) on November 23, 2016

Authors

Ji Yeon Hwang1,2, Sang Tae Kim3, Ho-Seong Han4, Kyunggon Kim5, Jin Soo Han6

Author Affiliations

1: Preclinical Research Center, Biomedical Research Institute, Seoul National University Bundang Hospital, 82, Gumi-ro 173beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 13620, Korea. labanimal@snubh.org.
2: The Institute for the 3Rs, College of Veterinary Medicine, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, Korea. labanimal@snubh.org.
3: Department of Surgery, Seoul National University Bundang Hospital, 82, Gumi-ro 173beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 13620, Korea. lingokst@snu.ac.kr.
4: Department of Surgery, Seoul National University Bundang Hospital, 82, Gumi-ro 173beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 13620, Korea. hanhs@snubh.org.
5: Asan Institute for Life Sciences, Asan Medical Center, Seoul, Department of Medicine, University of Ulsan College of Medicine, 43 gil Olympic-ro, Pungnap dong, Songpa gu, Seoul 138-736, Korea. kimkyunggon@gmail.com.
6: The Institute for the 3Rs, College of Veterinary Medicine, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, Korea. labvet@konkuk.ac.kr.

Articles cited by this

EMT and dissemination precede pancreatic tumor formation. Cell (2012) 9.27

Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst (2008) 5.74

The clinical utility of the CA 19-9 tumor-associated antigen. Am J Gastroenterol (1990) 3.20

EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res (2004) 2.78

Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study. Oncology (2012) 1.68

A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer (2011) 1.50

Oligonucleotide aptamers: new tools for targeted cancer therapy. Mol Ther Nucleic Acids (2014) 1.49

Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip. Lab Chip (2013) 1.23

RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule. Cancer Sci (2011) 1.19

Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture. Anal Chem (2013) 1.14

Microfluidic immunocapture of circulating pancreatic cells using parallel EpCAM and MUC1 capture: characterization, optimization and downstream analysis. Lab Chip (2014) 1.01

A Highlight of Recent Advances in Aptamer Technology and Its Application. Molecules (2015) 0.99

Aptamer-conjugated graphene oxide membranes for highly efficient capture and accurate identification of multiple types of circulating tumor cells. Bioconjug Chem (2015) 0.94

A cancer cell-activatable aptamer-reporter system for one-step assay of circulating tumor cells. Mol Ther Nucleic Acids (2014) 0.92

Novel MUC1 aptamer selectively delivers cytotoxic agent to cancer cells in vitro. PLoS One (2012) 0.89

Aptamers and their applications in nanomedicine. Small (2015) 0.88

Aptamer-quantum dots conjugates-based ultrasensitive competitive electrochemical cytosensor for the detection of tumor cell. Talanta (2011) 0.88

Circulating tumor cell detection using a parallel flow micro-aperture chip system. Lab Chip (2015) 0.87

Self-assembly of supramolecular aptamer structures for optical or electrochemical sensing. Analyst (2009) 0.85

Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells. Biomicrofluidics (2015) 0.82

Microinjection free delivery of miRNA inhibitor into zygotes. Sci Rep (2014) 0.80

The application of monoclonal antibodies in cancer diagnosis. Expert Rev Mol Diagn (2013) 0.78

The characterization of four gene expression analysis in circulating tumor cells made by Multiplex-PCR from the AdnaTest kit on the lab-on-a-chip Agilent DNA 1000 platform. Biochem Med (Zagreb) (2016) 0.78